malondialdehyde has been researched along with Day Blindness in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayton, SM; Muller, DP | 1 |
| Castillo, A; de la Casa, JM; Fernández-Cruz, A; Fernández-Durango, R; Fernández-Martínez, A; García-Bueno, B; García-Feijoo, J; Leza, JC; Pérez-Nievas, BG | 1 |
| Bhattacharya, M; Chemtob, S; Hanna, N; Hardy, P; Lachapelle, P; Ponka, P; Varma, DR | 1 |
3 other study(ies) available for malondialdehyde and Day Blindness
| Article | Year |
|---|---|
Vitamin E in neural and visual function.
Topics: alpha-Tocopherol; Animals; Diet; Electroretinography; Evoked Potentials, Somatosensory; Evoked Potentials, Visual; Lipid Peroxidation; Male; Malondialdehyde; Nervous System Diseases; Nutritional Requirements; Oxidative Stress; Rats; Rats, Wistar; Vision Disorders; Vitamin E; Vitamin E Deficiency | 2004 |
Expression of nitrotyrosine and oxidative consequences in the trabecular meshwork of patients with primary open-angle glaucoma.
Topics: Aged; Aged, 80 and over; Calcium; Gene Expression Regulation, Enzymologic; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lipid Peroxidation; Malondialdehyde; Middle Aged; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trabecular Meshwork; Tyrosine; Up-Regulation; Vision Disorders; Visual Field Tests; Visual Fields | 2008 |
Prevention of postasphyxia electroretinal dysfunction with a pyridoxal hydrazone.
Topics: Animals; Animals, Newborn; Asphyxia Neonatorum; Deferoxamine; Disease Models, Animal; Electroretinography; Humans; Hydrogen Peroxide; Infant, Newborn; Iron Chelating Agents; Isoniazid; Malondialdehyde; Oxidative Stress; Peroxides; Pyridoxal; Retina; Swine; Vision Disorders | 1997 |